Inhaled nitric oxide therapy in adults: European expert recommendations.
BACKGROUND
Inhaled nitric oxide (iNO) has been used for treatment of acute respiratory failure and pulmonary hypertension since 1991 in adult patients in the perioperative setting and in critical care.


METHODS
This contribution assesses evidence for the use of iNO in this population as presented to a expert group jointly organised by the European Society of Intensive Care Medicine and the European Association of Cardiothoracic Anaesthesiologists.


CONCLUSIONS
Expert recommendations on the use of iNO in adults were agreed on following presentation of the evidence at the expert meeting held in June 2004.
Germann
Peter
P
Department of Anaesthesiology and General Intensive Care, Medical University of Vienna, Waehringerguertel 18-20, 1090 Vienna, Austria. peter.germann@meduniwien.ac.at
Braschi
Antonio
A
Della Rocca
Giorgio
G
Dinh-Xuan
Anh Tuan
AT
Falke
Konrad
K
Frostell
Claes
C
Gustafsson
Lars E
LE
Hervé
Philippe
P
Jolliet
Philippe
P
Kaisers
Udo
U
Litvan
Hector
H
Macrae
Duncan J
DJ
Maggiorini
Marco
M
Marczin
Nandor
N
Mueller
Bernd
B
Payen
Didier
D
Ranucci
Marco
M
Schranz
Dietmar
D
Zimmermann
Rainer
R
Ullrich
Roman
R
D000280:Administration, Inhalation; D000328:Adult; D005060:Europe; D006333:Heart Failure / Q000628:therapy; D006801:Humans; D006976:Hypertension, Pulmonary / Q000628:therapy; D009569:Nitric Oxide / Q000008:administration & dosage / Q000627:therapeutic use*; D017410:Practice Guidelines as Topic; D015427:Reperfusion Injury / Q000628:therapy; D012128:Respiratory Distress Syndrome / Q000628:therapy; D012138:Respiratory Therapy / Q000379:methods
D009569:Nitric Oxide